NBIX Earnings History
Neurocrine Biosciences, Inc. has beat EPS estimates in 2 of the last 6 quarters.
| Date | EPS Est. | EPS Actual | Surprise | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| May 4, 2026 | 1.66 | N/A | N/A | $771.0M | N/A |
| Feb 11, 2026 | 2.25 | 1.88 | N/A | $775.6M | $805.5M |
| Oct 28, 2025 | 1.58 | 2.04 | N/A | $806.8M | $794.9M |
| Jul 30, 2025 | 0.98 | 1.06 | N/A | $746.4M | $687.5M |
| May 5, 2025 | 0.54 | 0.08 | N/A | $559.6M | $572.6M |
| Feb 6, 2025 | 1.62 | 1.00 | N/A | $629.4M | $627.7M |